Meet Replior at EADV Congress 2026
Supporting dermatology studies with
high-quality patient data
- Sep 30-oct 03 2026
- Vienna, Austria
About the EADV CONGRESS
Let’s talk dermatology research
Dermatology research is evolving beyond subjective assessments — with increasing interest in objective, continuous, and real-world measurements of disease activity and treatment response.
Replior’s wearables enable:
- Objective measurement of scratching behaviour and itch intensity
- Continuous, real-world data collection outside clinic visits
- High-resolution insights into treatment response over time
- Complementing PROs with sensor-based evidence
This approach helps reduce reliance on subjective reporting alone and supports more robust, data-driven clinical outcomes.
Advanced Tracking of Scratching Behavior and Sleep Patterns
The Replior scratch sensor, ScratchSense, is redefining how clinical trials capture critical data. This wearable, ring-like device detects scratching intensity, frequency, and patterns using advanced movement, position, and vibration analysis, while also tracking sleep patterns and ambient light levels—delivering insights that traditional methods can’t provide.
Integrated with the Trial Online™ ePRO app, it enables real-time, objective data capture to help clinical trial teams gain deeper understanding and improve study outcomes.
Objective UV Data for Dermatology & Cosmetic Studies
UV exposure plays a significant role in skin health, influencing inflammation, pigmentation, skin quality, and treatment response. Despite this, patient sun behaviour is rarely measured objectively in clinical research.
Replior’s UV sensor, RaySense, measures UVA/UVB radiation and visible light across red, green, and blue channels, providing real-time data tailored for dermatology and rare disease studies.
By capturing continuous UV exposure data, RaySense helps researchers better understand how environmental exposure may influence study outcomes—and separate treatment effects from external factors.
Visit us at Booth X2110
EADV Congress 2026